US Broker Ratings

AptarGroup, Inc. (ATR) Stock Report: Analyzing a 33.69% Upside Potential for Investors

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, stands out within the medical instruments and supplies industry. With a robust market capitalization of $8.72 billion, the company..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Unveiling a 13.95% Potential Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is garnering attention from investors with its promising 13.95% potential upside, making it a noteworthy player in the biotechnology sector. Headquartered in Carlsbad, California, Ionis..

Merck & Company, Inc. (MRK) Stock Analysis: A 29% Upside Potential Amid Strong Dividends

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, is capturing investor attention with its combination of robust dividends and a notable upside potential. With a market..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Leader with 18.5% Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG) has carved out a significant niche within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $9.95 billion,..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 42% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH) has recently caught the attention of investors with its robust growth trajectory and the significant potential upside it offers. With a market capitalization of..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth with a Solid Dividend Yield

For investors eyeing the healthcare sector, Johnson & Johnson (NYSE: JNJ) presents a compelling case with its robust market presence and diversified portfolio. As one of the most recognized names..

Charles River Laboratories (CRL) Stock Analysis: Assessing the 19.64% Upside Potential for Investors

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a cornerstone in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $7.31 billion, this..

Bruker Corporation (BRKR) Investor Outlook: Evaluating the 50% Upside Potential

Bruker Corporation (NASDAQ: BRKR), a stalwart in the healthcare sector focusing on medical devices, presents a compelling opportunity for investors keen on capitalizing on its projected growth. Headquartered in Billerica,..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 20% Potential Upside Amidst High Dividend Yield

Viatris Inc. (VTRS), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity for those looking to capitalize on..

Elevance Health, Inc. (ELV) Investor Outlook: Analyzing a 16.27% Potential Upside in the Healthcare Plans Sector

Elevance Health, Inc. (NYSE: ELV), a dominant player in the healthcare plans industry, offers a compelling case for investors seeking growth and income opportunities in the healthcare sector. With a..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring an 86.16% Potential Upside

ADMA Biologics Inc (ADMA), a key player in the biotechnology sector, is drawing investor attention with its notable 86.16% potential upside, as suggested by recent analyst ratings. Operating within the..

Bio-Techne Corp (TECH) Stock Analysis: Unveiling a 26.65% Upside Potential in the Biotechnology Sector

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust market presence and significant upside potential. With a market capitalization..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating Growth in the Biotechnology Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering company in the healthcare sector, particularly within the biotechnology industry, is making significant strides with its innovative therapeutics based on ribonucleic acid interference..

Gilead Sciences, Inc. (GILD) Rating Update: Analysts Project an 11.68% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD), a formidable player in the healthcare sector, continues to draw investor interest with its robust pipeline and strategic collaborations. As one of the leading drug..

Qiagen N.V. (QGEN) Stock Analysis: 18% Upside Potential Sparks Investor Interest

Qiagen N.V. (NYSE: QGEN), a leading player in the diagnostics and research industry, is garnering attention with its promising growth potential and strategic market positioning. Headquartered in Venlo, the Netherlands,..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: 71.20% Potential Upside Captivates Investors

Lantheus Holdings, Inc. (NASDAQ: LNTH) has emerged as a compelling opportunity in the healthcare sector, offering diagnostic and therapeutic solutions that play a critical role in the diagnosis and treatment..

Johnson & Johnson (JNJ) Stock Analysis: Healthcare Giant with a Solid Dividend Yield

Johnson & Johnson (NYSE: JNJ), a cornerstone of the healthcare sector, continues to command investor attention with its robust market capitalization of $432.8 billion. Founded in 1886 and based in..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the 80% Upside Potential Amidst Challenges

Moderna, Inc. (NASDAQ: MRNA), a leading player in the biotechnology sector, is currently navigating a complex landscape. The company, known for its pioneering work in messenger RNA (mRNA) medicines, is..

HealthEquity, Inc. (HQY) Stock Analysis: Unveiling a 26.76% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the health information services industry, has piqued the interest of investors with its promising growth trajectory and robust market presence. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds